FDA clears tests for coagulation disorder:
This article was originally published in Clinica
Executive Summary
The US FDA has cleared three immunoassays to help diagnose primary and secondary antiphospholipid syndrome, an autoimmune coagulation disorder that can lead to a variety of problems, such as miscarriage and stroke. Developed by Hemagen Diagnostics, the Virgo (beta)2 glycoprotein I IgA, IgG and IgM antibody kits will be available immediately, said the Waltham, Massachusetts-based company.